Savonix Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Liquidation
Savonix General Information
Description
Developer of a digital neuropsychology platform designed to assess and monitor cognitive health. The company's platform facilitates a mobile, evidence-based assessment of mental and emotional function and provides an accurate, accessible, real-time monitoring tool for professional cognitive screening of dementia, enabling healthcare providers to evaluate and leverage results to improve health and treatment outcomes.
Contact Information
Website
www.savonix.comCorporate Office
- 101 California Street
- Suite 1525
- San Francisco, CA 94133
- United States
Corporate Office
- 101 California Street
- Suite 1525
- San Francisco, CA 94133
- United States
Savonix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Bankruptcy: Liquidation | 27-Oct-2022 | Completed | Bankruptcy: Liquidation | |||
| 7. Secondary Transaction - Private | 30-May-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 12-Mar-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 04-Sep-2019 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jun-2019 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 25-Apr-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2019 | $1.5M | Completed | Generating Revenue | ||
| 1. Seed Round | 07-Dec-2017 | $1.5M | $1.5M | Completed | Generating Revenue |
Savonix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A3 | ||||||||
| Series A2 | ||||||||
| Series 4 | ||||||||
| Series 3 | ||||||||
| Series 2 | 6,002,002 | $0.000100 | 0.02% | $0.26 | $0.26 | 1x | $0.26 | 4.12% |
| Series 1 | 12,600,922 | $0.000100 | 0.02% | $0.41 | $0.41 | 1x | $0.41 | 8.64% |
Savonix Comparisons
Industry
Financing
Details
Savonix Competitors (30)
One of Savonix’s 30 competitors is BrainCheck, a Venture Capital-Backed company based in Austin, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BrainCheck | Venture Capital-Backed | Austin, TX | ||||
| Twill (Other Healthcare Technology Systems) | Formerly VC-backed | New York, NY | ||||
| CNS Vital Signs | Corporation | Morrisville, NC | ||||
| Pie Medical Imaging | Corporation | Maastricht, Netherlands | ||||
| MyndYou | Venture Capital-Backed | New York, NY |
Savonix Patents
Savonix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10188337-B1 | Automated correlation of neuropsychiatric test data | Inactive | 22-Aug-2015 | ||
| US-20190150819-A1 | Automated correlation of neuropsychiatric test data | Inactive | 22-Aug-2015 |
Savonix Signals
Savonix FAQs
-
When was Savonix founded?
Savonix was founded in 2014.
-
Where is Savonix headquartered?
Savonix is headquartered in San Francisco, CA.
-
What is the size of Savonix?
Savonix has 14 total employees.
-
What industry is Savonix in?
Savonix’s primary industry is Other Healthcare Technology Systems.
-
Is Savonix a private or public company?
Savonix is a Private company.
-
What is Savonix’s current revenue?
The current revenue for Savonix is .
-
How much funding has Savonix raised over time?
Savonix has raised $21.5M.
-
Who are Savonix’s competitors?
BrainCheck, Twill (Other Healthcare Technology Systems), CNS Vital Signs, Pie Medical Imaging, and MyndYou are some of the 30 competitors of Savonix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process